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Summary (141) 
 
Understanding the role of Notch and its ligands within the different bone marrow niches could 
shed light on the mechanisms regulating haematopoietic progenitor cells (HPCs) maintenance 
and self renewal. Here, we report that murine bone marrow HPCs activation by the vascular 
Notch Delta4 ligand maintains a significant proportion of cells specifically in the G0 state. 
Furthermore, Delta4/Notch pathway limits significantly the loss of the in vivo short-term 
reconstitutive potential upon transplantation of Delta-4 activated HPCs into lethally irradiated 
recipient mice. Both effects are directly correlated with the decrease of cell cycle genes 
transcription such as CYCLIN-D1, -D2, and -D3, and the upregulation of stemness related genes 
transcription such as BMI1, GATA2, HOXB4 and C-MYC. In addition, the transcriptional 
screening also highlights new downstream post-transcriptional factors, named PUMILIO1 and -2, 
as part of the stem signature associated with the Delta4/Notch signalling pathway. 
 
Keywords: Notch; Cell cycle; Haematopoietic Progenitor Cells, Dll4 protein, Pumilio 
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INTRODUCTION 
 
Haematopoietic Progenitor cells (HPCs) reside predominantly in the bone marrow (BM), where 
blood cell development occurs. The BM microenvironment is a complex system comprising 
nonhaematopoietic components such as bone-forming cells including mesenchymal stem cells 
and osteoblasts, fibroblasts, adipocytes, innervation from the sympathetic nervous system, 
reticular cells, pericytes, and endothelial cells [1]. It has long been recognized that 
nonhaematopoietic BM-derived stroma cells are capable of supporting long-term haematopoiesis 
in vivo and in vitro [2] and understanding the precise mechanism by which niche cells interact to 
regulate HPCs is critical for the development and improvement of stem cell therapies based on 
HPC manipulation and administration. 
The initial discovery that functional alterations in osteoblastic cells had consequences on HPC 
function attracted the interest of researchers in this field [3] [4]. A growing number of studies 
have subsequently implicated bone marrow vasculature, which consists of a vast network of thin-
walled, fenestrated sinusoidal endothelial cells and perivascular stromal cells as well as small 
arterioles, in providing the proper milieu of prohaematopoietic factors needed to support HPCs 
pool [5] [6]. 
The role of Notch signalling in adult vertebrate HPCs maintenance remained controversial, 
largely because gain- and loss-of-function studies have not produced consistent results. It has 
been suggested to be dispensable for adult haematopoiesis through two complementary 
approaches blocking the canonical Notch signalling within HPCs (one with a dominant negative 
form of the mastermind-like protein, and the other inactivating the RBP-J gene) [7] [8]. However, 
recent studies support a role for Notch in the regeneration of HPCs after injury [5] [9] and more 
recently, a role of endothelial Jagged-1 was highlighted for homeostatic and regenerative 
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haematopoiesis [10]. The Notch ligand Dll4 (Dll4) (Delta like 4, mbDll4) is specifically 
expressed on endothelial cells of the arteries, arterioles and capillaries [11] [12] and also on the 
perivascular stromal cells, and pericytes [13]. The specific expression of Dll4 in the vascular 
niche, known to exert an essential role in HPCs maintenance, attracted our interest for the role of 
the Dll4/Notch pathway in the bone marrow HPCs homeostasis. We have previously reported 
that the membrane-bound Notch ligand Dll4 (mbDll4) counteracts the proliferation of human 
cord blood CD34
+
 cells induced by cytokines and preserves a high LTC-IC potential in output 
CD34
+
 cells, even in cells having performed a similar number of divisions, indicating that LTC-
IC retention was mediated by mechanisms independent of the mitotic history [14] [15]. 
Here we report that Dll4 counteracts the proliferation of murine HPCs such as Lin
-
Sca
+
c-Kit
+
 
(LSK) cells, by keeping a higher fraction of cells in the G0 state. This event was correlated with a 
downmodulation of some key cell cycle genes transcription such as D-CYCLINS. Furthermore, 
Dll4 limits the loss of the short-term reconstitutive potential, as assessed by in vivo reconstitution 
assay, correlated with up-regulation of well-known self-renewal genes transcription such as 
BMI1, HOXB4, GATA2 and C-MYC as well as PUMILIO1 and -2, two RNA-binding proteins 
previously identified as regulators involved in stem cell proliferation in invertebrates. Altogether, 
these data reinforce the major role of the Notch ligand Dll4 in the vascular niche as a new player 
in HPCs maintenance. 
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MATERIALS AND METHODS 
 
Mice 
C57BL/6-Ly5.2, C57Bl/6-Ly5.1 (8-20 weeks old) were purchased from Janvier CERJ (Le 
Genest-St-Isle, France). All mice were maintained in the Gustave-Roussy Institute facilities 
under specific pathogen-free conditions. 
 
Cytometric analysis. 
Lineage negative Sca-1 and c-Kit positive (LSK) cell purification was performed as described by 
Spangrude and colleagues [16]. In some experiments, Lin
-
 and LSK cells were analysed using 
biotinylated mAbs raised against differentiation markers (Gr-1 clone RB6-8C5, Mac-1 clone 
M1/70, B220 clone RA3-6B2, CD3 clone 145-2C11 and Ter-119, mouse lineage panel, Becton 
Dickinson), revealed using streptavidin molecules, and stained with anti–Sca-1 mAb, (clone E13-
161.7) anti–c-Kit mAb (clone 2B8), and anti-CD150 mAb (clone TC15-12F12.2). Biotinylated 
CD41 (clone ebioscienceMWReg30) and CD48 (HM48-1) mAbs were added in the lin cocktail 
to analyse the SLAM phenotype. CD44 (clone 515) and CD25 (clone M-A2-51) mAbs were used 
to phenotype lymphoid precursors. Notch receptor expression was performed using anti-Notch 1 
(clone HMN-12), anti-Notch 2 (clone HMN2-35) and anti-Notch 4 (clone HMN4-14) antibodies 
(Biolegend). Isotype-matched antibodies were used as controls. Sorting of the LSK fraction was 
performed using a FACSvantage or an Aria III (Becton-Dickinson). 
 
Culture experiments 
Each of the S17 stroma cells (C/S17 and mbDll4/S17) were obtained and cultured as previously 
described [14]. LSK cells were cultured in 24-well plates coated with confluent C/S17 or 
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mbDll4/S17 in -MEM containing 10% FCS (Stem Cell Technology, Vancouver, Canada). The 
following cytokines were added: murine Stem Cell Factor muSCF, human Flt-3 ligand 
[HuFlt3-L], human interleukin-6 IL-6, each at 100 ng/mL, and human interleukin-11 [IL-11] at 
10 ng/mL. Some LSK cells were cultured on immobilized Dll4Fc (10 µg/ml) on plastic as 
previously described (Lauret et al., 2004), irrelevant human IgG1 served as a negative control. 
Some cultures were performed in the presence of 10mM DAPT (a gamma-secretase inhibitor: N-
{3,5-difluorophenacetyl)-L-alanyl}-S-phenylglycine-t-bytyl ester; Calbiochem, San Diego) or 
DMSO as vehicle. 
 
Cell-cycle analysis  
Carboxyfluorescein Succinimidyl Ester (CFSE) Staining. Before coculture, sorted LSK cells were 
incubated with CFSE 1 µM for 10 minutes at 37°C allowing protein staining. Cell divisions were 
analysed on a FACSort cytometer after two days in culture (Becton Dickinson). Ki-67 analysis. Ki67 
is a nuclear antigen associated with cell proliferation and is present throughout the  active cell cycle 
(G1, S, G2 and M phases) but absent in resting cells (G0). Cells were labelled with APC-anti-CD45 
mAb, incubated with a cytofix-cytoperm solution (Becton Dickinson), washed with a permwash 
solution (Becton Dickinson), and finally incubated with FITC-anti-Ki-67 mAb and DAPI before LSR 
cytometer analysis (Becton Dickinson). Pyronin/Hoechst analysis. FITC-anti-CD45 mAb labelled 
cells were incubated with 10 µg/ml Hoechst 33342 and 1 µg/ml Pyronin Y (RNA dye) (Sigma 
Chemical Co, St Louis, MO) at 37°C for 45 minutes in Hanks balanced salt solution (HBSS) medium 
supplemented with 2mM Hepes, 10% FBS and 1mg/l glucose [17]. 
 
Long-Term Culture-Initiating Cell (LTC-IC) and CFC assay 
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Long-term culture-initiating cell (LTC-IC) assay was performed as described by Sutherland and 
colleagues [18]. The cultures were recovered after 5 weeks and assayed for the presence of myeloid 
culture colony-forming unit (CFU-C) using a methylcellulose medium (M3234; Stem Cell 
Technologies, Vancouver, BC, Canada) supplemented with cytokines. After 7 to 10 days of growth at 
37°C, colonies were scored with an inverted microscope based on their morphology. 
 
Long-term competitive repopulation assay 
C57Bl/6 (Ly5.2) mice were used as recipients, whereas LSK cells were prepared from C57Bl/6 
(Ly5.1) donors. Lethally irradiated recipients were cotransplanted with 1.5 x 10
5 
Ly5.2 BM cells 
together with various amounts of cells exposed to S17 stroma or immobilized Dll4Fc protein for 
7 days, injected into the retro-orbital sinus of mice. Haematopoietic reconstitution was assessed 
at 4 and 16 weeks after transplantation through analysis of blood or bone marrow respectively. 
Analysis of the presence of CD45.1
+
 cells in blood and bone marrow of reconstituted mice at 4 
and 16 weeks after transplant was performed using flow cytometry with a cut-off 0.1% CD45.1
+
 
(donor) cells for at least 10
5
 analysed cells (FACS Sort). Animals displaying greater than 0.1% of 
CD45.1
+
 positive cells were considered as positive for repopulation. 
 
Microarray 
Total RNAs from sorted cell populations were isolated using the RNAplus kit (Qbiogene) and 
further amplified using the MessageAmp aRNA kit (Ambion, Austin, TX). The integrity of the 
RNA samples was verified using an Agilent Bioanalyzer (Palo Alto, CA). The cDNAs were 
labelled and hybridized to the murine microarray manufactured in CEA microarray platform as 
described [19]. Slides were scanned with a Genepix 4000 microarray scanner (Axon Instruments, 
Molecular Devices, Sunnyvale, CA). Images were processed to acquire Cy5 and Cy3 fluorescence 
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intensities for each hybridized spot using Genepix Pro 4.0 software (Axon Instruments). Spots or 
areas of the array with obvious blemishes were flagged and excluded from subsequent analysis. 
Result files were imported into GeneSpring 6.1 software (Silicon Genetics, Agilent) for further 
analyses. To eliminate dye-related artefacts in 2-color experiments, intensity-dependent Lowess 
normalization was performed. The results represent the average of 8 independent measures and 
were deposited in the Gene Expression Omnibus (GEO) database 
(http://www.ncbi.nlm.nih.gov/geo/) with the GSE 5135 accession number. Differentially 
expressed genes were obtained by analysis of variance using ANOVA parametric test (P<0.01) 
followed by Benjamini and Hochberg multiple test correction. For stringent comparisons, only 
probes with a hybridization value in at least 6 of 8 replicates were considered for further analysis. 
 
Quantitative reverse-transcriptase (RT)-PCR 
Total RNA was extracted from cells using the Trizol reagent (InVitrogen). Synthesis of first-
strand cDNAs was performed using oligo(dT) and Superscript II reverse transcriptase 
(Invitrogen). PCR was performed using SYBRGreen PCR Master Mix (PE Applied Biosystems, 
Foster City, CA). PCR was monitored with a GeneAmp 5700 sequence detection system (PE 
Applied Biosystems). Quantification was performed using the Ct values method. The primers 
used are indexed in Supplementary data Table S1. 
 
Statistical Analysis 
All measurements were performed at least three times. Continuous variables were analysed using 
Student’s t-test for paired values. The measured values were expressed as mean  SEM. p-values 
of less than 0.05 were considered to be statistically significant. 
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RESULTS 
 
Dll4 maintains a fraction of HPCs out of the cycle 
We first examined Notch receptor expression on murine bone marrow HPCs. The majority of 
LSK cells expressed the Notch 2 receptor (79.7±1.8 %), while few of them expressed Notch 1 
(29.1±9.3 %) and Notch 4 (13.9±3.0 %) (Figure S1). Our data confirmed the major role of Notch 
2 in governing the rate of generation of mouse long- and short-term repopulating stem cells, as 
previously described [9, 20]. To assess mbDll4 activities on murine HPCs, LSK cells were 
cultivated with cytokines on control (C) and mbDll4 stromas (mbDll4). After a 7-day culture, the 
fold increase in total cell number was significantly reduced (1200±90 onto C versus 600±72 onto 
mbDll4, p<0.05, Figure 1A), indicating that mbDll4 reduced total cell expansion. Apoptosis 
analysis did not revealed any difference in the percentage of apoptotic cells between C and 
mbDll4 population neither at day 2 (12±5 % for C versus 13±4 % for mbDll4 culture) nor at 7 
days of culture (data not shown), thus precluding a potential role of apoptosis in the reduction of 
cell expansion upon mbDll4 stimulation. 
Labeling of cells with Carboxyfluorescein Diacetate Succinimidyl Ester to simultaneously 
monitor cell divisions at 2 days of culture when both populations were homogenous, still 
displaying 90% Lin
-
 cells (data not shown), showed that the proportion of cells not dividing or 
dividing once was significantly higher in the population exposed to mbDll4 as compared to C 
(3±0 % for C versus 6±0 % for mbDll4 culture at 0 division, p=0.02 and 15±0 % for C versus 
19±0 % for mbDll4 culture at one division, p<0.05), while the proportion of cells having 
performed 4 divisions was lower in the population exposed to mbDll4, as compared to cells 
grown on C (18±2 % for C versus 12±2 % for mbDll4 culture, p<0.05, Figure 1B). 
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To precisely decrypt the modifications in the cell cycle and separate the G0 and G1 states, we 
used Ki-67/DAPI staining to estimate the frequencies of G0 (Ki67
-
; 2N DNA content), G1 (Ki-
67
+
; 2N DNA content), and S/G2/M (Ki-67
+
; >2N DNA content). According to these markers, 
we found a higher proportion of LSK cells exposed to mbDll4 in the G0 state (7±1 % for LSK 
exposed to C versus 13±2 % for LSK cells exposed to mbDll4 culture, p<0.05), with a 
significant modification in the proportion of cells in S/G2/M (47±2 % for C versus 37±3 % for 
mbDll4, p<0.05, Figure 1C). These modifications in the cell cycle were confirmed by Pyronin-Y 
(PY) and Hoechst 33342 (Ho) staining (Figure 1D). These data showed that mbDll4 counteracts 
the stimulatory proliferative effects of cytokines by maintaining out of the cycle a higher fraction 
of LSK cells. 
 
Dll4 downmodulates expression of D-cyclins 
To identify potential Dll4-dependent genes implicated in the cell cycle, we used a chimeric 
Dll4Fc protein for a stimulation set up independent of the stroma cell context. We first 
confirmed the antiproliferative activity of Dll4Fc on LSK cells. When cultured on immobilized 
Dll4Fc, HPCs displayed a reduced cell expansion as compared to control populations at day 7 of 
the culture (Figure S2A). Furthermore, analysis at day 2 of RNA/DNA contents by Pyronin-Y 
(PY) and Hoechst 33342 (Ho) staining revealed a higher proportion of cells in the G0 state (6±2 
% for C versus 14±5 % for Dll4Fc, p<0.05, Figure S2B), with a significant modification in the 
proportion of cells in S/G2/M (49±3 % for LSK cells exposed to C versus 37±6 % for LSK cells 
exposed to Dll4Fc, p<0.05) (Figure S2B), as previously showed for mbDll4. Next, we assessed 
the expression of some key downstream cell cycle target genes 12h after exposure to Dll4Fc 
(before their first division). As shown in Figure 2, we observed a transcriptional upregulation of 
p130 (1.33±0.11, p=0.02), E2F4 (2.4±0.18, p=0.02) and Rb (2.7±0.41, p=0.04) genes and a 
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downregulation of CYCLIN-D1 (0.26 ±0.01, p=0.02), CYCLIN-D2 (0.27±0.02, p=0.03) and 
CYCLIN-D3 genes (0.38±0.05, p=0.04) after exposure to Dll4Fc. In contrast, the level of 
transcriptional expression of p18
INK4c
, p19
INK4d
, p21
Cip1/Waf1
, p27
Kip1
, p57
Kip2
, cdk1, cdk4, cdk6, 
Dmtf1, p107 and CYCLIN-E1, CYCLIN-E2 genes were not modified after exposure of HPCs to 
Dll4Fc (data not shown). 
 
Dll4 limits the loss of HPCs primitive potential 
We also examined the effects of mbDll4 on the LSK cells by following the proportion of LSK 
cells throughout a 7-day culture on C and mbDll4 stromas. A progressive decline in the % of 
LSK cells on the C stroma compared to the mbDll4 stroma became significant at day 2, and this 
difference increased progressively to reach 5-fold more LSK cells on mbDll4 stroma at day 7 
(7±4% for C versus 38±0% on mbDll4, p<0.05, Figure 3A and B). We did not notice any 
significant difference in the proportion of the different lineages among Lin
+
 cells, indicating that 
in our culture conditions, mbDll4 did not favour differentiation toward a particular myeloid 
lineage (Figure S3A). Nevertheless, we noticed at day 7 the appearance of a small number of 
CD44
+
/CD25
+
 (markers of early T cell differentiation) cells upon mbDll4 stimulation, as 
observed in previous studies (Figure S3B)[21]. 
To further characterize the primitive potential of cells generated after 7 days of culture on both 
stromas, we monitored their in vitro CFC and LTC-IC as well as their in vivo repopulating 
activity. Cells cultured on mbDll4 maintained a higher proportion of clonogenic colonies (48±8 
CFC per 500 Lin
-
 on C versus 68±20 CFC per 500 output Lin
-
 cells on mbDll4, p<0.05, Figure 
3C). The increased CFC number was the result of a general increase in all types of colonies 
(CFU-GM, BFU-E, and mixed colonies). Furthermore, colonies generated on mbDll4 displayed a 
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larger size, as compared to those derived from Lin
-
 cells on C (data not shown). The LTC-IC 
potential of output LSK cells generated on mbDll4 was preserved at day 7, compared to the one 
of input bone marrow LSK cells (18±4 LTC-IC-derived CFC/1000 for output LSK versus 24±0.5 
for 1000 output LSK cells from mbDll4 culture), while this potential was strongly impaired in 
output LSK cells generated onto C (1.9±0.1 LTC-IC-derived CFC/1000 output LSK cells, 
p=0.03, Figure 3D). This leads to a strongly enhanced expansion of LTC-IC-derived CFC (251±7 
LTC-IC-derived CFC for C versus 4825±110 LTC-IC-derived CFC for mbDll4 from 1,000 input 
LSK cells, p<0.05, Figure 3E). 
The in vivo repopulating activity was assessed by examining the short-term reconstitution in the 
peripheral blood (4 weeks), and the long-term in the bone marrow (> 16 weeks) (Figure 4 and 
Figure S4). To cast off the expansion difference between control and mbDll4 cultures, we 
injected all the progeny of Ly5.1 LSK cells (ranging from 10 to 200 LSK seeded cells) grown for 
7 days on C and mbDll4, independently on the number of cells grown in these two conditions, 
together with a fixed number of Ly5.2 bone marrow competitor cells into irradiated Ly5.2 
recipients. While no chimerism was detected in mice infused with cells grown onto C stroma at 4 
or 16 weeks, 14 to 40% of mice were chimeric at 4 and 16 weeks with cells grown onto mbDll4 
stroma (Figure 4A), with a chimerism dependent on the amount of cells injected (from 0.06±0.03 
for 10 LSK cells to 2.2±0.9 for 200 LSK cells, chimerism at 4 weeks with cells grown onto 
mbDll4 stroma, Figure 4B). When analysed at 16 weeks post-transplantation, low levels of bone 
marrow cell chimerism (ranging from 0.1 to 1%, data not shown) were observed in mice injected 
with the progeny of 10 to 200 LSK cells cultivated onto mbDll4, while no chimerism could be 
detected for mice injected with the progeny of control LSK cells. These data indicated that 
exposure to mbDll4 limits significantly the loss of the in vivo reconstitutive potential at least in 
short term analysis. 
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To confirm the implication of Notch signalling in mbDll4 activity, we analysed the requirement 
of the -secretase complex, which is an essential effector in the Notch signalling pathway. When 
LSK cells were cultured on mbDll4 for 7 days in the presence of DAPT (an inhibitor of the -
secretase), cell expansion was restored (857±88 for cells onto mbDll4 in the presence of DAPT 
versus 298±48 for cells cultured on mbDll4 with DMSO, Figure S5A), and the maintenance of a 
high proportion of LSK cells on mbDll4 was abrogated (4±1 for cells onto mbDll4 in the 
presence of DAPT versus 26±5 % for cells cultured onto mbDll4 with DMSO, respectively, 
Figure S5B). 
 
Identification of downstream target genes modulated by Dll4 
To reveal new signalling pathways involved in the effects of Dll4 on HPCs, we performed a 
differential transcriptomic analysis of HPCs cultured for 6 or 12 h with or without Dll4Fc. First, 
we confirmed the similarity of the HPCs response between immobilized Dll4Fc and mbDll4. 
HPCs cultured for 7 days on immobilized Dll4Fc maintained a higher proportion of LSK cells 
(5±2 for C versus 22±7 % for Dll4Fc culture, p<0.05, Figure S6A), retained a primitive 
potential, evidenced by an LTC-IC potential identical to the input cells, leading to an enhanced 
expansion of LTC-IC-derived CFC (16±3 for C versus 323±19 for Dll4Fc culture, p<0.05, 
Figure S6B), and a higher in vivo reconstitution potential when inoculated into irradiated mice 
(78% of chimeric mice at 16 weeks post-transplant for Dll4Fc cultures versus 12% of chimeric 
mice for control cultures, Figure S6C). 
Using the ANOVA parametric test (p<0.01) and Benjamini and Hochberg multiple testing 
correction, we found 559 modulated probes for Dll4Fc cultures and 64 modulated probes for 
control cultures after 12 hours of culture versus non-cultured LSK cells. To provide a biological 
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interpretation of these gene expression modifications, we looked for statistical significance of the 
enrichment of particular functional categories using Ingenuity pathways analysis (IPA) and 
DAVID resources (http://david.abcc.ncifcrf.gov/home.jsp), focusing particularly on Gene 
Ontology (GO) Biological Process terms. We found that most of the genes were included in 
three significant GO categories: “Cell Growth and Proliferation”, “Cell Cycle Process” and 
“Translation Process” (Figure S7). Very few genes were modulated at 6hr (data not shown). 
Interestingly, one of the upregulated genes at this early time was HOXB4 (1.8±0.4, p=0.01). 
Changes in gene expression observed at 12h were confirmed by RT-qPCR on a series of selected 
genes encompassing all the scale of modulations (Figure 5), validating thus the microarray data. 
Genes such as GATA2 (2.4±0.4, p=0.04), HES1 (4.7±1.8, p=0.01), BMI1 (5.1±2.3, p=0.01), EED 
(1.7±0.2, p=0.002), and C-MYC (13.9±1.5, p=0.007) were already known to be involved in stem 
cell self-renewal [22-28]. The chaperone HSP90 protein (1.4±0.1, p=0.01), and the transcription 
factor MNT (6.9±1.2, p=0.03) were not previously identified as involved in this process. In 
addition, the post-transcriptional repressor gene PUMILIO2 (PUM2) identified in invertebrates 
and previously described in other models to be involved in stem cell fate or expansion [29, 30], 
was also found highly upregulated (6.8±1.1, p=0.04). Therefore, we measured the transcription 
levels of PUMILIO1 (PUM1) (absent in the microarray) by RT-qPCR. The results show that 
PUM1 transcription was also upregulated in response to Dll4 (2.9±0.7, p=0.04), suggesting that 
both mammalian PUMILIO proteins might potentially play an important role in Notch-ligand 
Dl14-dependent cell development and differentiation. We also confirmed the down regulation of 
Osteopontin (OPN) (0.3±0.04, p=0.01) and the CCL12 chemokine (0.3±0.06, p=0.04). 
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DISCUSSION 
 
In accordance with our previous work performed on human CD34
+ 
CD38
low
 cord blood cells 
[14]), mbDll4 reduces murine bone marrow HPCs cell expansion correlated with the retention of 
their primitive potential in vitro. The present study further reveals that the reduced cell 
proliferation was mainly due to the maintenance of a higher proportion of HPCs in the G0 state. 
It also shows that cell culture on mbDll4-expressing stroma limits the loss of their short term 
repopulating capacity in vivo, and finally leads to the identification of the gene signature of HPCs 
in response to Notch/Dll4 signalling. 
 
Maintenance of a higher proportion of LSK cells out of the cycle 
The vascular niche has been demonstrated to maintain HPCs in vivo [5]. Endothelial and 
perivascular cells play a key role as main producers of SCF [31], and CCL12 [32] in the bone 
marrow. Furthermore, both of them support HPCs maintenance ex vivo [5]; [20]. The 
maintenance of quiescence is also a key feature for regulating HPCs homeostasis. Using the 
signalling lymphocyte attractant molecule (SLAM) family markers to identify quiescent HPCs, 
several studies report that most quiescent HPCs are localized adjacent to blood vessels in the 
bone marrow [31, 33, 34]. Only a few of the external factors governing HSCs quiescence in the 
vascular niche have been identified among which Tie2/Angiopoietin-1 play a major role [35]. 
Dll4 has been shown to be expressed in endothelial and perivascular cells [13]; [36].
 
We have 
previously shown that the exposure of human CD34
+
 cells to mbDll4 maintains a high proportion 
of cells in the G0/G1 phase without distinguishing the G0 phase from the G1 phase. The present 
data further revealed a higher proportion of HPCs in the G0 phase, in spite of our cell culture 
conditions based on strong cytokine activation, suggesting that Dll4-expressing cells participate 
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to the maintenance of HPCs out of the cell cycle. To our knowledge, Dll4 is the only Notch 
ligand described as keeping HPCs out of the cycle. 
To get insight into the mechanisms of Dll4 activity, we examined the transcriptional modulation 
of some cell cycle genes. The D-cyclin family, CYCLIN-D1, CYCLIN-D2, and CYCLIN-D3 genes 
were all transcriptional expressed, albeit at different levels, in HPCs [37]. CYCLIN D1
-/-
D2
-/-
D3
-/-
 
embryos displayed a reduced numbers of fetal HPCs, with impairment in their ability to 
proliferate, revealing a unique requirement for the D-CYCLINS in the haematopoietic lineage 
[38]. The transcriptional downmodulation of the 3 D-CYCLINS genes observed in response to 
Dll4 is therefore in complete agreement with the key role of D-CYCLINS in HPCs proliferation. 
E2F4, which can bind to all 3 pRB family members to form the majority of cellular pRB family 
complexes, has been proposed to play a critical role in coordinating cell cycle exit [39]. The 
retinoblastoma (Rb) family of transcriptional repressors, including the pRb, p107 and p130 
proteins, restricts cell cycle entry by regulating E2F gene transcription of positive cell cycle 
regulators. Conditional deletion of all three Rb family members in adult mice resulted in a robust 
cell-intrinsic myeloproliferation phenotype, with an increase in HPCs proliferation, and severe 
defects in self-renewal [40]. Therefore, the transcriptional upregulation of E2F4 and Rb genes in 
response to Dll4 is consistent with their role in the cell cycle. Taken together, these findings 
indicate that Cyclins D and Rb family members may play a critical role in the activity of the 
Dll4/Notch pathway for the maintenance of the quiescent state. 
 
mbDll4 limits the loss of HPC potential in vitro and in vivo 
Exposure of LSK cells to mbDll4, not only preserves their in vitro CFC and LTC-IC potential, 
but also limits the loss of the in vivo short-term reconstitutive potential, as compared to LSK cells 
cultured in control conditions. A chimeric Delta1Fc (Dll1Fc), immobilized on the plastic, thus 
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mimicking the membrane-bound form, was previously used, showing an improvement of the 
long-term reconstitutive potential of BM LSK cells or human cord blood CD34
+
 cells cultivated 
with Dll1 [41]; [42]. Exposure of LSK cells to mbDll4 showed a limited in vivo long-term 
reconstitutive potential, despite preserving the in vitro CFC and LTC-IC potential. We suggest 
that Dll4 contributes to the short-term bone marrow reconstitution, thus allowing rapid recovery 
of homeostasis in response to stress. 
Exposure of LSK cells to Dll4 was correlated with an enhanced transcriptional expression of 
HES1, the well-known Notch target gene. A recent study suggests that SE complex/Notch 
signalling controls early HPC commitment decisions in bone marrow, partly through the Hes 
family of transcriptional repressors [43]. Furthermore, overexpression of HES1 in LSKCD34
-
 
cells leads in vivo to an accumulation of the primitive SP cells and LSKCD34
-
 cells in marrow of 
recipient mice, while maintaining the production of the differentiated blood cells [24]. However, 
its role on the cell cycle is still controversial: an overexpression of HES1 in human CD34
+
 cells 
reduced their proliferation [44], while a comparable study led to an increase in the incorporation 
of BrdU in HES1-overexpressing cells, with a reduction in apoptosis and an increase in their 
capacity to expand in NOD-SCID mice [45]. Different levels of HES1 expression may be at the 
origin of these contrasting effects. 
To identify the downstream mechanisms involved in Dll4 activity, we have compared the 
transcriptional response of HPCs exposed to Dll4 to control HPCs. Our comparative study of the 
transcriptome has provided us with a skeleton of an answer by revealed upregulation of some 
genes already identified to be implicated in the regulation of HPC self-renewal such as BMI1 
[25], HOXB4 [22], EED [26], GATA2 [23] and C-MYC [27]; [28]. Transcriptional screening has 
also highlighted new up-regulated candidate genes, PUMILIO1 and -2, downstream of the 
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Dll4/Notch signalling pathway. Among the post-transcriptional regulators of stem cells, PUM 
proteins, which belong to the evolutionary highly conserved family of PUF proteins, have been 
shown to be central for the maintenance of germinal and somatic stem cells in invertebrate. They 
are able to bind specific motifs mainly present in the 3’-untranslated region (3’UTR) of target 
mRNAs, thus favoring sets of mRNA’s to be degraded or kept untranslated. The fact that PUF 
genes are targets of Notch signalling in HPC was previously observed in C. elegans germline 
stem cells, the expression of the FBF2 gene being under the control of GLP-1/Notch signalling 
[46]. Activation of PUF genes by Notch signalling in both C. elegans germ stem cells and murine 
HPCs enforces the link between these two major mechanisms regulating stem cell mitoses. 
However the implication of PUM proteins in the function of mammalian stem cells has been 
rarely addressed, only few reports have highlighted a possible role of PUM2 and two invertebrate 
PUM partners (NANOS and TRIM32) in the primitive potential of murine embryonic and adult 
spermatogonial and neural stem cells, respectively [29, 30]; [47]. Interestingly, a connection 
between PUF proteins and another main regulator of HSCs maintenance such as HOXB4/C4 was 
stressed through a previous study [48]. Comparative transcriptome analyses of human CD34
+
 
cells subjected or not to HOXB4 or HOXC4 genes have revealed that both homeoproteins 
upregulate PUM1 and PUM2 encoding genes. The link between Pumilio and Dll4/Notch pathway 
in the function of HPCs will be further investigated. 
 
CONCLUSION 
 
Our observations strongly indicate that the vascular Notch/Dll4 ligand exerts a dormant activity 
on HPCs, distinct from other Notch ligands, and displays clear-cut positive effects on the 
maintenance of the primitive functions of murine HPCs in culture. Furthermore, the link between 
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Pumilio and Dll4/Notch pathway in the function of HPCs is a new understanding step in the 
mechanism of the Notch signalling pathway. These newly identified factors, PUM1 and PUM2 
could be implicated in the expansion and maintenance of HPCs. 
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LEGENDS OF FIGURES 
 
Figure 1: mbDll4 reduces cell proliferation by keeping a fraction of cells in G0. 
(A) Fold increase in total cell number. Sorted BM LSK cells were cultivated in 24-well plates 
(500-1000 cells per well) coated with C or mbDll4 stromas in the presence of mSCF, hFlt3-L, 
hIL-6 and mIL-11. Haematopoietic cells were harvested at day 7 and the fold increase in total cell 
number was calculated by dividing the number of output cells at day 7 by the number of input 
LSK cells, *= p<0.05. (B) High resolution tracking of cell division. Carboxyfluorescein Diacetate 
Succinimidyl Ester-labelled (CFSE) LSK cells were cultured in wells coated with C or mbDll4 
stroma in the presence of the same cocktail of cytokines. Flow cytometry analysis of CFSE
+
 cells 
was made after 2 days of culture. Percentage means represent the area of each peak (FACS 
analysis of one representative experiment). The percentages represent the mean of 3 experiments. 
Dashed lines illustrate single divisions, which are differentiated by losing CFSE fluorescence at 
each division. (C) Distribution of cells in G0 versus G1 and S/G2M phase of the cell cycle using 
Ki-67 and DAPI staining. Sorted BM LSK cells cultivated as previously described were 
harvested at day 2, and were stained with Ki-67 Ab (proliferating cells) and DAPI (DNA dye). 
Cells residing in G0 appear at the bottom of the G0/G1 peak, G1 cells are in the upper part and 
S/G2/M cells are at the right hand side of the G1 peak as indicated. (D) Distribution of cells in 
G0 versus G1 and S/G2M phase of the cell cycle using Hoechst and Pyronin staining. Sorted BM 
LSK cells were cultivated as previously described. Cells harvested at day 2 were stained with 
Pyronin (proliferating cells) and Hoechst (DNA dye). Cells residing in G0 appear at the bottom 
of the G0/G1 peak, G1 cells are in the upper part and S/G2/M cells are at the right hand side of 
the G1 peak as indicated. Results are presented as the mean ± SEM in triplicate assays. Data are 
expressed as mean ± SEM, n=3, p< 0.05. 
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Figure 2. Analysis of gene expression of regulators involved in cell cycle in response to Dll4. 
Quantitative real time PCR was performed to validate the microarray data. PCR amplifications 
were carried out in triplicate on RNA prepared from LSK cells exposed or not to Dll4Fc for 12 
hours (3 independent experiments). The mRNA expression of each gene was normalized to that 
of TF2D mRNA. The final ratios, expressed as a fold change, were generated by comparing 
expression levels of LSK cells exposed to Dll4Fc compared to control cells. Results are presented 
as the mean ± SEM in triplicate assays, p<0.05. 
 
Figure 3: mbDll4 limits the loss of the in vitro primitive potential. 
LSK cells were cultivated on C and mbDll4 stromas in the presence of mSCF, hFlt3-L, hIL-6 and 
mIL-11. (A) LSK cell maintenance. Cells harvested at the indicated days throughout the culture 
were labelled to identify the percentage of LSK cells in the total nucleated cell population. (B) 
LSK cell analysis after 7 days. FACS profiles of output LSK cells in one representative 
experiment (out of three) after seven days of culture. (C) CFC potential of Lin
-
 cells. 500 sorted 
Lin
-
 cells at day 7 were cultured in methylcellulose, and the number of erythroid (BFU-E), 
myeloid (CFU-GM) and mixed colonies were measured after 7 days. Results are expressed as 
mean  SEM of ten different experiments, each performed in triplicate, *= p<0.05. (D) LTC-IC 
potential of LSK cells. 200 input and output LSK cells from each condition were cultured for 5 
weeks on MS-5 cells, and cells from each well were then plated in methylcellulose and the 
number of CFC-derived LTC-IC was counted after 7 days (mean ± SEM of four independent 
experiments, *= p<0.05). (E) Expansion of LTC-IC derived CFC. Histogram represents the 
number of LTC-IC derived CFC per 1000 input LSK cells. The total number of LTC-IC-derived 
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CFC cells was calculated using the total cell count, and the percentages of LSK cells. Data are 
expressed as mean ± SEM, n=3, *= p<0.05. 
 
Figure 4: mbDll4 limits the loss of the short-term reconstitution potential. 
In vivo reconstitution potential. Progeny of 10 to 200 sorted Ly5.1 LSK cells cultivated in the 
conditions previously described, were harvested at day 7, mixed with fresh 1.5 x 10
5
 Ly5.2 BM 
cells and transplanted into lethally irradiated C57B6 Ly5.2 mice (5 to 8 mice per group). 
Analysis of the presence of CD45.1
+
 cells in blood and bone marrow of reconstituted mice at 4 
and 16 weeks after transplant was performed using flow cytometry with a cut-off 0.1% CD45.1 
(donor)
+
 cells for at least 10
5
 analysed cells (FACS Sort). Table A presents the frequency of 
reconstitution at 4 and 16 weeks after transplant, and panel B the average chimerism 4 weeks 
after transplant in recipient mice, *= p<0.05. 
 
Figure 5. Analysis of gene expression of regulators involved in self-renewal in response to 
Dll4. 
Quantitative real time PCR was performed to validate the microarray data. PCR amplifications 
were carried out in triplicate on RNA prepared from LSK cells exposed or not to Dll4Fc for 12 
hours (3 independent experiments). The mRNA expression of each gene was normalized to that 
of TF2D mRNA. The final ratios, expressed as a fold change, were generated by comparing 
expression levels of cells exposed to Dll4Fc compared to controls. Results are presented as the 
mean ± SEM in triplicate assays, p<0.05. 
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Figure S1. Notch receptor expression on murine bone marrow LSK cells. Antibody staining 
with conjugated anti Notch-1, anti Notch-2, and anti Notch-4. Notch receptor expressions (red 
histograms) are overlaid on isotype controls (gray histograms) for the same population. 
 
Figure S2. Dll4Fc reproduces mbDll4 activities by reducing cell expansion and keeping a 
fraction of cells in G0. 
LSK cells were cultured for seven days in wells precoated with immobilized Dll4Fc as described 
in MM. Cultures with IgG1 served as a negative control. (A) Fold increase in total cell number. 
The fold increase in total cell number was calculated by dividing the number of output cells at 
day 7 by the number of input LSK cells. (B) Distribution of cells in G0 versus G1 and S/G2M 
phase of the cell cycle. LSK cells harvested at day 2 were stained with Pyronin (proliferating 
cells) and Hoechst (DNA dye). Cells residing in G0 appear at the bottom of the G0/G1 peak, G1 
cells are in the upper part and S/G2/M cells are at the right hand side of the G1 peak as indicated. 
Results are presented as the mean ± SEM in triplicate assays, * p<0.05. 
 
Figure S3: Effects of mbDll4/S17 on myeloid and lymphoid differentiation. 
LSK cells were cultured in wells coated with C or mbDll4 in the presence of mSCF, hFlt3-L, 
hIL-6, and hIL-11 for 7 days. (A) Phenotype of nucleated cells after 7 days of culture on C and 
mbDll4 stromas was performed using monoclonal markers Gr-1, MAC-1, B220, CD4, CD8 and 
TER-119 specifically expressed by granulocytes, macrophages, B lymphocytes, T lymphocytes 
and erythrocytes, respectively, and immature markers, Sca-1 and c-Kit. Results are presented as 
the mean ± SEM in 3 experiments. (B) CD44
+
 CD25
+
 Lin
-
 cell phenotype of nucleated cells after 
7 days of culture on C and mbDll4 stromas was performed using monoclonal markers GR-1, 
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MAC-1, B220, TER-119 (for Lin minus lineage), CD44 and CD25 (for T cell commitment). 
Results are presented as the mean ± SEM in 3 experiments. 
 
Figure S4: Flow cytometric profiles of in vivo reconstitution potential. 
Progeny of 10 to 200 sorted Ly5.1 LSK cells cultivated in the conditions previously described, 
were harvested at day 7, mixed with fresh 1.5 x 10
5
 Ly5.2 BM cells and transplanted into lethally 
irradiated C57B6 Ly5.2 mice (5 to 8 mice per group). The chimerism of engrafted mice was 
analyzed using CD45.1 (clone A20), and CD45.2 (clone 104) mAbs. Flow cytometric profiles of 
CD45.1
+
 and CD45.2
+
 cells in peripheral blood at 4 weeks (A) and in bone marrow at 16 weeks 
(B) of representative engrafted mice, after transplant. Analyses were performed with a cut-off 
0.1% CD45.1
+
 (donor) cells for at least 10
5
 analysed CD45
+
 cells. 
 
Figure S5. mbDll4 activates the Notch pathway.  
Sorted LSK cells were cultivated with or without DMSO or DAPT (30 µM). Cells were harvested 
at day 7, and counted. (A) Effect of the presence of DAPT on the fold increase in total number of 
cells. (B) The percentage of LSK cells was estimated after 7 days of cultures on C and mbDll4 
with or without DAPT. All data represent the mean ± SEM, n=3, *= p<0.05. 
 
Figure S6. Dll4Fc reproduces mbDll4 activities by limiting the loss of the reconstitution 
potential. 
LSK cells were cultured for seven days in wells precoated with immobilized Dll4Fc as described 
in MM. Cultures with IgG1 served as a negative control. (A) LSK cell analysis after 7 days. 
FACS profiles of output LSK cells in one representative experiment (out of three) after seven 
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days of culture. (B) LTC-IC potential of LSK cells. Expansion of LTC-IC-derived CFC after 
seven days of culture, *= p<0.05 (n=3). (C) In vivo reconstitution potential. Reconstitution 
potential of cells exposed to Dll4Fc. Progeny of 300 Ly5.1 LSK cells cultivated in the conditions 
previously described were harvested at day 7, mixed with 1.5x10
5
 Ly5.2 BM cells, and 
transplanted into lethally irradiated C57Bl6/J Ly5.2 mice (5 to 7 per group). Analysis of the 
presence of CD45.1
+
 cells in bone marrow (4 and 16 weeks reconstitution) of reconstituted mice 
was performed using flow cytometry (FACS Sort). 
 
Figure S7. Overrepresented functional categories modulated in response to Dll4. 
Functional analysis of genes modulated in LSK cells exposed to Dll4Fc for 12 hr, using GO, 
terms from DAVID database (http://david.abcc.ncifcrf.gov/home.jsp). 
 
Table S1. Sequences of RT-qPCR primers. 
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Highlights 
.  The Notch/Delta4 pathway maintains a proportion of HPCs out of the cell cycle. 
. The Notch/Delta4 pathway limits in vivo the loss of HPCs primitive potential. 
. PUMILIO-1 and -2 are new downstream factors of the Notch/Delta4 pathway. 
